Variable CD7 Expression on T Cells in the Leukemic Phase of Cutaneous T Cell Lymphoma (Sézary Syndrome)
- 1 September 2001
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 117 (3) , 654-662
- https://doi.org/10.1046/j.1523-1747.2001.01456.x
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Human TH1 and TH2 subsets: doubt no morePublished by Elsevier ,2004
- T-cell receptor gene analysis in the diagnosis of Se ́zary syndromeJournal of the American Academy of Dermatology, 1999
- Immunophenotyping and T-cell receptor γ gene rearrangement analysis as an adjunct to the histopathologic diagnosis of mycosis fungoidesJournal of the American Academy of Dermatology, 1998
- Detection of circulating T cells with CD4+CD7− immunophenotype in patients with benign and malignant lymphoproliferative dermatosesJournal of the American Academy of Dermatology, 1996
- CD7-positive Sézary syndrome with a Th1 cytokine profileJournal of the American Academy of Dermatology, 1996
- Diagnosis of Sézary syndrome in a patient with generalized pruritus based on early molecular study and flow cytometryJournal of the American Academy of Dermatology, 1995
- Crosslinking of the T cell-specific accessory molecules CD7 and CD28 modulates T cell adhesion.The Journal of Experimental Medicine, 1992
- T-cell receptor gene rearrangement analysis: Cutaneous T cell lymphoma, peripheral T cell lymphoma, and premalignant and benign cutaneous lymphoproliferative disordersJournal of the American Academy of Dermatology, 1991
- Leu-8 and Leu-9 antigen phenotypes: Immunologic criteria for the distinction of mycosis fungoides from cutaneous inflammationJournal of the American Academy of Dermatology, 1986
- Pre-Sézary Erythroderma Evolving to Sézary SyndromeArchives of Dermatology, 1983